USPTO serial 86767176
TELIGENT PHARMA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PENDLETON, CAROLYN A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TELIGENT PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Danielle I. Mattessich
DANIELLE I. MATTESSICH Merchant & Gould P CPO Box 2910Minneapolis, MN 55402-0910UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, ophthalmic preparations, topical anesthetics, antifungal preparations; Pharmaceutical preparations in the nature of herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; antifungal preparations; Pharmaceutical products and preparations to reduce swelling and decrease the body's immune response; anti-inflammatories; topical anesthetics; Pharmaceutical preparations in the nature of non-steroidal anti-inflammatory drugs that are administered only orally; Antibiotic preparations; Pharmaceutical preparations, namely, dantrolene sodium for injection; Injectable dermal filler; Pharmaceutical preparations for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: lower respiratory tract, skin and skin-structure, urinary tract, bacterial septicemia, bone and joint, gynecological, intra-abdominal, and CNS infections, septicemia, meningitis, and gonorrhea | ACTIVE | — |
| 040 | Manufacturing of pharmaceutical preparations for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IGI Laboratories, Inc.
- Other trademarks owned by TELIGENT, INC.
- Other trademarks owned by TELIGENT, INC.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Similar marks named TELIGENT PHARMA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 27, 2016 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 26, 2016 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 24, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 29, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 29, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 9, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 19, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 17, 2016 | ALIE | ASSIGNED TO LIE | — |
| Feb 3, 2016 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 14, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 14, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 14, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 14, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 14, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 5, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 1, 2015 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Sep 30, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 28, 2015 | NWAP | NEW APPLICATION ENTERED | — |